用fezolinetant治疗中度至严重的更年期血管运动症状:使用两个第三阶段研究 (SKYLIGHT 1和2) 的汇总数据对响应者的分析
Rossella E Nappi, Kimball A Johnson1, Petra Stute2
1iResearch Atlanta, LLC, Decatur, GA.
Menopause (New York, N.Y.)
|April 16, 2024
概括
费索利尼坦有效地减少了绝经期中度至重度的血管运动症状 (VMS),显示了患者报告结果的显著改善. 这种治疗为患有VMS的女性提供了临床上有意义的改变.
科学领域:
- 生殖医学 生殖医学
- 临床药理学 临床药理学
- 妇女健康 妇女健康
背景情况:
- 血管运动症状 (VMS) 在绝经期间显著影响生活质量.
- 目前对VMS的治疗选择有局限性.
- 费索利内坦是用于VMS治疗的试验性神经素3受体对抗剂.
研究的目的:
- 用响应分析评估fezolinetant在治疗中度至重度VMS中的疗效.
- 为了确定是否fezolinetant提供临床上有意义的患者内改善,独立于安慰剂效应.
主要方法:
- 来自两个第三期,随机,双盲,安慰剂对照试验 (SKYLIGHT 1和2) 的数据汇总.
- 响应者分析定义为≥50%,≥75%,≥90%,或100%减少VMS频率在第4周和第12周.
- 评估患者报告的结果 (PROs),包括睡眠障碍和生活质量,以定义单个,双重和三重反应者.
主要成果:
- 与安慰剂相比,治疗费佐利内坦的患者比例更高,达到≥50%,≥75%,≥90%,并减少了100%的VMS频率.
- 费索利尼坦在12周的单,双和三重响应分析中显示出更高的响应率.
- 在组合的PRO分析中,赔率比率有利于fezolinetant的有益作用.
结论:
- 费索利内坦治疗导致VMS频率在患者内部显著改善.
- 在关键的PRO中观察到临床上有意义的改善,包括睡眠和生活质量指标.
- 费索利内坦在改善更年期VMS影响的多个领域方面表现出有效性.
更多相关视频
05:32Author Spotlight: Investigating the Relationship Between FSH and Pathophysiological Changes in Perimenopausal Women - Insights from a Mouse Model
Published on: August 11, 2023
1.7K
04:34Meta-Analysis of the Effectiveness and Safety of Shugan Jieyu Capsules for the Treatment of Insomnia
Published on: February 17, 2023
1.1K
相关概念视频
01:28Menopause
156
Menopause, a natural biological process marking the end of a woman's fertility, typically occurs between the fifth and sixth decade of life. This phase is characterized by the exhaustion of the ovarian follicle pool, leading to less responsive ovaries despite the high levels of Follicle Stimulating Hormone (FSH) and Luteinizing Hormone (LH). The consequential decrease in estrogen production results in symptoms like hot flashes, heavy sweating, headaches, hair loss, muscle pains, vaginal...
156
01:23Antidepressant Drugs: MAOIs and Other Agents
227
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
227
01:17Sedatives and Hypnotics Drugs: Miscellaneous Agents
171
Sedatives and hypnotics encompass a wide range of substances, each with its unique mechanism of action, uses, and potential adverse effects.
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
171
01:12Analysis of Population Pharmacokinetic Data
254
Analysis of population pharmacokinetic data involves studying the behavior of drugs within diverse populations to understand their pharmacokinetic parameters. Traditional pharmacokinetic methods typically involve collecting samples from a few individuals and estimating these parameters. While these methods are commonly used, they have limitations in capturing the variability in drug response among individuals or heterogeneous populations. Population pharmacokinetics is employed to address these...
254